Blueprint Medicines Corp logo

Blueprint Medicines Corp

FRA:2L9 (USA)  
€ 95.04 (+0.19%) May 22
At Loss
P/B:
20.88
Market Cap:
€ 5.93B ($ 6.42B)
Enterprise V:
€ 5.63B ($ 6.10B)
Volume:
-
Avg Vol (2M):
125.00
Also Trade In:

Blueprint Medicines Corp Operating Data

Blueprint Medicines Corp Competitors' Latest Operating Data

Operating data not available.

Blueprint Medicines Corp (FRA:2L9) Operating Data Charts